A carregar...
Novel Glutamatergic Treatments for Severe Mood Disorders
All currently approved antidepressant medications for major depressive disorder (MDD) and bipolar disorder act primarily on the monoaminergic system and have varying affinities for serotonergic, norepinephrine-ergic, and/or dopaminergic receptors. Unfortunately, these drugs are only effective in app...
Na minha lista:
| Publicado no: | Curr Behav Neurosci Rep |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4725605/ https://ncbi.nlm.nih.gov/pubmed/26824031 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40473-015-0050-5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|